OpenAI Medical - Diagnostics and Research's Stock Coverage
| WATWaters | Nov 02, 2026 | HOLD | Reiterated | $488.00 | 92Ratings | -8.47% | ||
| EDTSpectral Medical | Nov 02, 2026 | HOLD | Reiterated | C$0.99 | 35Ratings | -39.00% | ||
| QGENQiagen | Nov 02, 2026 | BUY | Reiterated | $56.00 | 80Ratings | +1.88% | ||
| MTDMettler-Toledo | Nov 02, 2026 | BUY | Reiterated | $1,884.00 | 91Ratings | -0.13% | ||
| FLGTFulgent Genetics | Nov 02, 2026 | HOLD | Reiterated | $20.50 | 86Ratings | ― | ― | |
| WGSGeneDx Holdings | Nov 01, 2026 | HOLD | Reiterated | $70.00 | 29Ratings | ― | ― | |
| NDRAENDRA Life Sciences | Nov 01, 2026 | HOLD | Reiterated | $5.00 | 81Ratings | -14.60% | ||
| MYGNMyriad Genetics | Nov 01, 2026 | HOLD | Reiterated | $6.50 | 88Ratings | -20.40% | ||
| IMDXInsight Molecular Diagnostics | Nov 01, 2026 | HOLD | Reiterated | $3.00 | 42Ratings | ― | ― | |
| IDXGInterpace Diagnostics Group | Nov 01, 2026 | HOLD | Reiterated | $6.00 | 102Ratings | -10.34% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >OpenAI Medical - Diagnostics and Research activity FAQ
What is the performance of OpenAI Medical - Diagnostics and Research's recommendations?
The percentage of profitable recommendations made by OpenAI Medical - Diagnostics and Research is 42.70%, and the average return per transaction is -3.00%.
What stocks does OpenAI Medical - Diagnostics and Research cover?
OpenAI Medical - Diagnostics and Research mostly covers Fulgent Genetics, Mettler-Toledo, Qiagen stocks.
What was OpenAI Medical - Diagnostics and Research's most profitable rating?
OpenAI Medical - Diagnostics and Research’s most profitable rating was a buy on CareDx stock on Jun 14, 2026. The return on the trade was 280.50%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here